Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads
Status: | Recruiting |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 21 - 90 |
Updated: | 6/20/2018 |
Start Date: | March 1, 2015 |
End Date: | July 2019 |
Contact: | Jennifer L Miller, PhD |
Email: | jenn.miller@uky.edu |
Phone: | 859-323-8907 |
The Family Sodium Watcher program in this study is designed to improve adherence to a sodium
restricted diet in patients with HF using strategies that educate both patients and family
caregivers about sodium monitoring and that stress a gradual progressive adaptation to low
sodium food for both patients and family caregivers.
restricted diet in patients with HF using strategies that educate both patients and family
caregivers about sodium monitoring and that stress a gradual progressive adaptation to low
sodium food for both patients and family caregivers.
Heart failure (HF) emerged as a significant public health threat in the 1990s and has now
reached epidemic proportions. Despite advances in the medical treatment of HF, patients with
HF face frequent hospitalizations for acute exacerbations. Inadequate self-care strategies,
in particular non-adherence to a sodium restricted diet (SRD), is a main cause of these
rehospitalizations. Prior interventions to increase adherence have focused on increasing
knowledge about restricting sodium in the diet have met with limited success. Unaddressed by
these interventions are the major barriers of measuring and tracking daily sodium intake,
family members who continue to eat high sodium diets, and a preference for salty
foods—particularly in the elderly who have a decreased sense of taste. It is possible to
retrain the taste buds to enjoy low salt foods by gradually reducing the amount of sodium in
foods over the course of 16 weeks. This retraining works best with direct involvement and
support from family members. The Family Sodium Watcher Program (Family SWaP) proposed in this
study incorporates the use of a unique electronic salt monitoring device that easily measures
salt content in food—the major source of sodium. The intervention is designed to improve
adherence to a SRD by both patients and family caregivers through education and strategies
for gradual taste adaptation to low salt foods.
reached epidemic proportions. Despite advances in the medical treatment of HF, patients with
HF face frequent hospitalizations for acute exacerbations. Inadequate self-care strategies,
in particular non-adherence to a sodium restricted diet (SRD), is a main cause of these
rehospitalizations. Prior interventions to increase adherence have focused on increasing
knowledge about restricting sodium in the diet have met with limited success. Unaddressed by
these interventions are the major barriers of measuring and tracking daily sodium intake,
family members who continue to eat high sodium diets, and a preference for salty
foods—particularly in the elderly who have a decreased sense of taste. It is possible to
retrain the taste buds to enjoy low salt foods by gradually reducing the amount of sodium in
foods over the course of 16 weeks. This retraining works best with direct involvement and
support from family members. The Family Sodium Watcher Program (Family SWaP) proposed in this
study incorporates the use of a unique electronic salt monitoring device that easily measures
salt content in food—the major source of sodium. The intervention is designed to improve
adherence to a SRD by both patients and family caregivers through education and strategies
for gradual taste adaptation to low salt foods.
Inclusion Criteria:
Eligible patients will:
- have diagnosis of chronic HF with either preserved or reduced ejection fraction
- have a dedicated primary family caregiver
- be able to speak and write English
Eligible caregivers will:
- be a primary caregiver identified by the patient
- the spouse, committed partner, or family member living with the HF patient
- be able to speak and understand English
- have no obvious major clinical cognitive impairment that would impair ability to give
informed consent
- have no major co-morbidities (i.e. HF, cancer, renal/liver failure, or uncontrolled
diabetes as determined by self-report).
Exclusion Criteria:
Patients will be excluded if they have:
- major clinical cognitive impairment (i.e., dementia, Alzheimer disease, and severe
stroke)
- a co-existing terminal illness (e.g., cancer)
- a referral for heart transplantation
- a dietary prescription that prevents following a 2-3 gram sodium diet (e.g., clinician
does not support use of a SRD).
- no dedicated caregivers
We found this trial at
1
site
Click here to add this to my saved trials